Jubilant - Forest Labs collaboration to discover small molecure drug candidates

Jubilant Organosys Ltd has informed that Jubilant Biosys Ltd., a subsidiary of the Company and Forest Laboratories Holdings Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. on December 06, 2007 announced that the Companies have entered into a collaboration agreement to discover small molecule drug candidates for a novel metabolic disorders target.

Jubilant Biosys will conduct the drug discovery work and Forest will have responsibility for the subsequent pro-clinical and clinical development. Forest will own the drugs discovered under the collaboration with unencumbered worldwide commercialization rights. Under the terms of the collaboration, Forest will pay Jubilant undisclosed amounts towards research funding, development and commercialization milestones.

Commenting on the development, Mr. Shyam S Bhartia, chairman & Managing Director and Mr. Hari S Bhartia, Co-Chairman & Managing Director of Jubilant Organosys said; "We are very pleased to partner with Forest Laboratories, an important pharmaceutical Company. This collaboration leverages the innovation capabilities of Jubilant Biosys in pharmaceutical discovery and preclinical development, as well as combining these strengths with Forest Laboratories, a proven successful development and commercialization Company, to deliver new products with cost effective efficiency that will help patients around the world. This partnership continues to demonstrate Jubilant's strategy to be Indias's largest innovation driven integrated pharmaceutical services provider supporting the global pharmaceutical industry."